← Product Code [JXG](/submissions/NE/subpart-f%E2%80%94neurological-therapeutic-devices/JXG) · K061876 # CODMAN VPV SYSTEM, MODEL 82-3192 (K061876) _Codman & Shurtleff, Inc. · JXG · Oct 16, 2006 · Neurology · SESE_ **Canonical URL:** https://fda.innolitics.com/submissions/NE/subpart-f%E2%80%94neurological-therapeutic-devices/JXG/K061876 ## Device Facts - **Applicant:** Codman & Shurtleff, Inc. - **Product Code:** [JXG](/submissions/NE/subpart-f%E2%80%94neurological-therapeutic-devices/JXG.md) - **Decision Date:** Oct 16, 2006 - **Decision:** SESE - **Submission Type:** Traditional - **Regulation:** 21 CFR 882.5550 - **Device Class:** Class 2 - **Review Panel:** Neurology - **Attributes:** Therapeutic ## Indications for Use The CODMAN® VPV™ System is designed for use only with CODMAN® HAKIM™ Programmable Valves in the treatment of hydrocephalus when shunting cerebrospinal fluid (CSF) from the ventricles of the brain. It is used to non-invasively adjust the CODMAN HAKIM Programmable Valve to the selected setting and provides confirmation of the valve adjustment, without the need for radiographic imaging when an "Adjustment Complete" message is displayed. ## Device Story The CODMAN VPV System is an accessory used by clinicians to non-invasively adjust the settings of implanted CODMAN HAKIM Programmable Valves. The system consists of a programming unit, transmitter unit, power cord, and ultrasound gel. The clinician operates the device to transmit adjustments to the valve; the system provides confirmation of the adjustment via an "Adjustment Complete" message, eliminating the need for radiographic imaging. This allows for precise, non-invasive management of CSF shunting to meet individual patient clinical needs. ## Clinical Evidence No clinical data. Substantial equivalence based on physical, mechanical, and in vitro performance testing. ## Technological Characteristics System includes programming unit, transmitter unit, power cord, and ultrasound gel. Non-invasive adjustment mechanism for programmable valves. Class II device (21 CFR 882.5550). ## Regulatory Identification A central nervous system fluid shunt is a device or combination of devices used to divert fluid from the brain or other part of the central nervous system to an internal delivery site or an external receptacle for the purpose of relieving elevated intracranial pressure or fluid volume (e.g., due to hydrocephalus). Components of a central nervous system shunt include catheters, valved catheters, valves, connectors, and other accessory components intended to facilitate use of the shunt or evaluation of a patient with a shunt. ## Predicate Devices - CODMAN® VPV™ System ([K050739](/device/K050739.md)) ## Reference Devices - Medtronic's PS Medical Strata® Valves and Handtools ([K040943](/device/K040943.md)) ## Submission Summary (Full Text) > This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com. > > Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/). {0}------------------------------------------------ ### Premarket Notification CODMAN® VPV™ System ### SECTION 6. - 510(k) Summary (As Required By 21 CFR 807.92(a)) A. Company Information > Codman & Shurtleff, Inc. 325 Paramount Drive Raynham. MA 02767-0350 Establishment Registration Number: 1226348 #### B. Contact Person Susan Kagan Senior Regulatory Affairs Specialist Telephone Number: 508-880-8097 Fax Number: 508-828-2777 DATE: June 30, 2006 #### C. Device Information Propriety / Trade Name: CODMAN® VPV™ System Common Name: Hydrocephalus Shunt System Predicate Device: CODMAN® VPV™ System (K050739) #### D. Classification This device has been placed in Class II for Central Nervous System Fluid Shunt and Components devices per 21 CFR 882.5550 (84JXG). Classification Panel: Neurology #### E. Device Description The CODMAN® VPV™ System (VPV) is an accessory (multiple use) indicated for use only with the CODMAN® HAKIM Programmable Valve, in the treatment of hydrocephalus when shunting cerebrospinal fluid (CSF) from the ventricles of the brain. The system is comprised of the program unit, transmitter unit, a power cord, carrying case, and ultrasound gel. The VPV System allows the clinician to noninvasively increase or decrease the valve setting to meet the patient's particular clinical needs. 2. 1 of 2 OCT 16 2006 061876 {1}------------------------------------------------ #### Li Indications For Use The CODMAN® VPV™ system is designed for use only with CODMAN® HAKIM™ Programmable Valves in the treatment of hydrocephalus when shunting cerebrospinal fluid (CSF) from the ventricles of the brain. It is used to noninvasively adjust the CODMAN HAKIM Programmable Valve to the selected setting and provides confirmation of the valve adjustment, without the need for radiographic imaging when an "Adjustment Complete" message is displayed. #### G. Device Testing Substantial equivalence for this device was based upon performance testing (physical and mechanical testing) and in vitro testing. Test results demonstrate substantial equivalence of the product to commercially distributed predicate devices for the same intended use. #### H. Statement of Substantial Equivalence The CODMAN VPV System is identical to the currently marketed predicate VPV device (K050739) in terms of physical characteristics, programming and procedure. The CODMAN VPV System is substantially equivalent to Medtronic's PS Medical Strata® Valves and Handtools (K040943) with regard to Indications for Use and labeling. P. 2 of 2 {2}------------------------------------------------ Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health and Human Services. The logo consists of a circular seal with the words "DEPARTMENT OF HEALTH AND HUMAN SERVICES. USA" arranged around the perimeter. Inside the circle is a stylized symbol that resembles a caduceus, a traditional symbol of medicine, but with three parallel lines instead of a single staff. Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 OCT 1 6 2006 Codman & Shurtleff, Inc. % Ms. Susan Kagan Senior Regulatory Affairs Specialist 325 Paramount Drive Raynham, Massachusetts 02767-0350 Re: K061876 Trade/Device Name: CODMAN® VPV™ System Regulation Number: 21 CFR 882.5550 Regulation Name: Central nervous system fluid shunt and components Regulatory Class: II Product Code: JXG Dated: September 6, 2006 Received: September 7, 2006 Dear Ms. Kagan: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the udicions for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cometic Act (Act) that do not require approval of a premarket approval application (PMA). You mosil therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulterstion. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. {3}------------------------------------------------ Page 2 - Ms. Susan Kagan This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0115. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html. Sincerely yours. for Mark N. Melkerson Mark N. Melkerson Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {4}------------------------------------------------ ## SECTION 5. Indication for Use Statement # Indications for Use KO61876 510(k) Number (if known): Device Name: CODMAN® VPV™ System Indications For Use: The CODMAN® VPV™ System is designed for use only with CODMAN® HAKIM™ Programmable Valves in the treatment of hydrocephalus when shunting cerebrospinal fluid (CSF) from the ventricles of the brain. It is used to non-invasively adjust the CODMAN HAKIM Programmable Valve to the selected setting and orovides confirmation of the valve adjustment, without the need for radiographic imaging whos on "Adjustment Complete" message is displayed. Prescription Use X (Part 21 CFR 801 Subpart D) AND/OR Over-The-Counter Use (21 CFR 807 Subpart C) ## (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) (Division Sign-Off) Division of General, Restorative, and Neurological Devices Page 1 of 1 | CONFIDENTIAL | 510(k) Number: 4061876 | June 30, 2006 | |--------------|------------------------|---------------| | | 14 | | --- **Source:** [https://fda.innolitics.com/submissions/NE/subpart-f%E2%80%94neurological-therapeutic-devices/JXG/K061876](https://fda.innolitics.com/submissions/NE/subpart-f%E2%80%94neurological-therapeutic-devices/JXG/K061876) **Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact). **Cite:** Innolitics at https://innolitics.com